123/A, Miranda City Likaoli
Prikano, Dope
+0989 7876 9865 9
+(090) 8765 86543 85
info@example.com
example.mail@hum.com
Gastrointestinal (GI) cancer refers to cancers that develop in the digestive tract and associated organs, including the esophagus, stomach, intestines, liver, pancreas, and rectum. These cancers can affect digestion, nutrient absorption, and overall health, requiring specialized treatment.
✔ Esophageal Cancer – Affects the esophagus, often linked to acid reflux or smoking.
✔ Stomach (Gastric) Cancer – Develops in the stomach lining, commonly due to Helicobacter pylori infection.
✔ Colorectal Cancer – Affects the colon or rectum and is one of the most common GI cancers.
✔ Liver Cancer (Hepatocellular Carcinoma) – Often linked to hepatitis infections or liver cirrhosis.
✔ Pancreatic Cancer – A fast-spreading cancer with limited early symptoms.
✔ Gallbladder & Bile Duct Cancer – Rare cancers affecting the biliary system.
✔ Small Intestine Cancer – Affects the small bowel, disrupting digestion and nutrient absorption.
Gastrointestinal cancers are diagnosed through endoscopy, colonoscopy, imaging scans (CT, MRI), biopsy, and blood tests (tumor markers like CEA and AFP). Treatment depends on the stage and location:
✔ Higher Survival Rates – Early detection significantly improves outcomes.
✔ Minimally Invasive Techniques – Faster recovery with robotic and laparoscopic surgery.
✔ Improved Digestion & Nutrient Absorption – Specialized care ensures better post-treatment digestive function.
✔ Personalized Treatment Plans – Tailored therapies reduce side effects and improve quality of life.
With advanced medical technologies and specialized care, gastrointestinal cancer patients have a better chance of early detection, effective treatment, and long-term survival.